Paramount stock rises after FCC approves Skydance merger
RICHMOND, VA - Indivior PLC (NASDAQ/LSE:LON:INDV) will release its second quarter 2025 financial results on Thursday, July 31, at 7:00 a.m. ET, the pharmaceutical company announced Thursday.
Following the financial release, Chief Executive Officer Joe Ciaffoni and other members of the leadership team will host a presentation via webcast at 8:00 a.m. ET.
Indivior, which specializes in treatments for opioid use disorder (OUD), employs over 1,000 people globally and markets its products in more than 30 countries. The company focuses on developing medications to treat OUD as part of its mission to transform opioid use disorder from what it describes as a global crisis to a recognized and treated chronic disease.
The quarterly results presentation will be accessible through the investor relations section of the company’s website, with options for both webcast viewing and telephone participation.
The announcement was made in a press release statement issued by the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.